Status:
UNKNOWN
Autoimmunity in Retinitis Pigmentosa
Lead Sponsor:
Semmelweis University
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
Phase:
NA
Brief Summary
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.
Eligibility Criteria
Inclusion
- Clinical diagnosis of retinitis pigmentosa
Exclusion
- Cataract
- Extremely low ERG wave amplitude (less than 8% of normal)
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00433277
Last Update
February 9 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semmelweis University, Dept. of Ophthalmology
Budapest, Hungary, H-1085